After the FDA reported dozens of pharmaceutical issues involved with Paxlovid, an antiviral treatment for mild-to-moderate COVID-19 symptoms, the Institute for Safe Medication Practices updated its safe practice list for pharmacists June 30.
Read the full post on Becker's Hospital Review - Healthcare News
